GSK_WRN4

N/A

Report date: 2025/03/21 09:44:20
NME

Base Information

Drug NameGSK_WRN4
Drug Alias NameGSK_WRN4GSK-WRN4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN inhibitors
TargetsBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Therapy Area/IndicationsMicrosatellite Instability
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsMicrosatellite Instability
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A